The Expanding Role of PD-1 Inhibitors in Cancer Treatment

March 22, 2019

By: John C. Paschold, MD - Virginia Oncology Associates

Since 2006, when the first clinical trial began testing the effectiveness of PD-1 inhibitors, the use of these immunotherapy drugs has increased dramatically. Over the last two to three years, these drugs have moved from research trials into mainstream cancer treatment, particularly for late stage melanoma, lung cancers, kidney cancers, and head and neck cancers.

Read More Categories: Cancer Research, Cancer Treatment

Novel Treatments in Lung Cancer See Expanded Use

January 4, 2019

By: Graham T. Watson, MD – Virginia Oncology Associates

The quickly expanding knowledge of cancer biology has led to new, highly effective treatments for patients with non-small cell lung cancer. Advances in genetics have brought about targeted therapy with drugs that “target” a specific driver mutation. With deeper understanding of the immune system’s interaction with cancer cells, we can uncloak cancer cells that previously hid from immune destruction. For years, we have leveraged these therapies only in Stage IV lung cancer, but research has shown that that Stage III patients treated first with chemoradiotherapy can also gain benefit.

 Immunotherapies such as nivolumab (Opdivo®) or pembrolizumab (Keytruda®) have helped patients with incurable, Stage IV, lung cancer live longer. While these drugs represent a major breakthrough, limiting their use to Stage IV patients is a frustration for both patients and doctors. While the goal of treatment in Stage III lung cancer patients is cure, the rates of recurrence are high. Finding treatment that can reduce this risk of recurrence is a worthy goal.

Read More Categories: Lung Cancer, Cancer Research, Cancer Treatment

Cancer Research is Advancing Breast Cancer Treatment Options

September 25, 2018

By David Z. Chang, MD,PhD, FACP

Recent developments in breast cancer treatment have continued to fuel our movement toward tailored treatment for each individual patient.

Two of the newest and most promising fronts are targeted therapy and immunotherapy. Both aim to more effectively kill cancer cells while sparing healthy tissue, thereby causing fewer debilitating side effects as compared to traditional chemotherapy.

Read More Categories: Breast Cancer, Cancer Research, Healthcare Providers

Clinical Trials Expand Treatment Options for Cancer in Hampton Roads

January 30, 2018

For people with cancer, having access to all available treatment options for their specific type of cancer can be difficult. Specialized cancer clinical trials and research may require extensive travel or even relocation to be closer to hospitals or research institutes conducting such studies. Fortunately, for residents of Hampton Roads, this is not the case.

One of the largest and most reputable cancer research networks in the world is US Oncology Research, which specializes in Phase I-IV oncology clinical trials in communities throughout the nation. Our location here in Hampton Roads is one of 16 Translational Oncology Program (TOP) sites for US Oncology Research, offering the largest clinical research program in the region.

Read More Categories: Cancer Research

1